Try our new research platform with insights from 80,000+ expert users
WithSecure Elements Endpoint Protection Logo

WithSecure Elements Endpoint Protection Reviews

Vendor: WithSecure
4.0 out of 5

What is WithSecure Elements Endpoint Protection?

Featured reviews

WithSecure Elements Endpoint Protection mindshare

As of December 2024, the mindshare of WithSecure Elements Endpoint Protection in the Endpoint Protection Platform (EPP) category stands at 0.6%, down from 0.8% compared to the previous year, according to calculations based on PeerSpot user engagement data.
Endpoint Protection Platform (EPP)

PeerAnalyst reports

TypeTitleDate
CategoryEndpoint Protection Platform (EPP)Dec 17, 2024Download
ProductReviews, tips, and advice from real usersDec 17, 2024Download
ComparisonWithSecure Elements Endpoint Protection vs Microsoft Defender for EndpointDec 17, 2024Download
ComparisonWithSecure Elements Endpoint Protection vs SentinelOne Singularity CompleteDec 17, 2024Download
ComparisonWithSecure Elements Endpoint Protection vs CrowdStrike FalconDec 17, 2024Download
Suggested products
TitleRatingMindshareRecommending
CrowdStrike Falcon4.311.0%97%122 interviewsAdd to research
Microsoft Defender for Endpoint4.011.5%94%190 interviewsAdd to research
 
 
Key learnings from peers

Valuable Features

Room for Improvement

ROI

Pricing

Popular Use Cases

Service and Support

Deployment

Scalability

Stability

Top industries

By visitors reading reviews
Computer Software Company
19%
Government
14%
Comms Service Provider
12%
University
5%
Manufacturing Company
5%
Retailer
5%
Construction Company
4%
Educational Organization
4%
Hospitality Company
3%
Non Profit
3%
Wholesaler/Distributor
3%
Healthcare Company
3%
Financial Services Firm
3%
Consumer Goods Company
2%
Media Company
2%
Real Estate/Law Firm
2%
Security Firm
2%
Energy/Utilities Company
1%
Recreational Facilities/Services Company
1%
Outsourcing Company
1%
Legal Firm
1%
Logistics Company
1%
Agriculture
1%
Aerospace/Defense Firm
1%
Insurance Company
1%
Performing Arts
1%
Pharma/Biotech Company
1%